Healthcare Consulting China

WE REALIZE YOUR CHINA-RELATED
HEALTHCARE PROJECTS

SILREAL offers a wide range of consulting services with the ultimate goal of supporting European companies with their market entry and expansion strategies to China and vice-versa. Working with our clients from start to finish, we help develop new ideas, define effective strategies and implement sustainable solutions resulting in measurable success for our clients in their international business.

"Our mission is to advance the cooperation between the healthcare systems of

Germany and China."

Healthcare Consulting China

The Chinese healthcare market offers numerous opportunities as well as challenges for German companies

Digitalisierung healthcare China

DIGITALIZATION

Benefits of the chinese healthcare sector

STRATEGIC GUIDELINES

Consulting im healthcare in China

IMPORTANCE OF HEALTH

  • Digital ecosystem: Around 850 million active internet users and 40% digital natives

  • Expansion of the digital infrastructure: Investments of up to € 360 billion in the 5G expansion (by 2030)

  • Digital infrastructure offers opportunities to establish innovative digital health offers across the board

  • Close cooperation between the state and the private sector in order to strive for the modernization and competitiveness of the health system

  • Healthy China 2030 is seen as a driver to increase supply efficiency, cost transparency and resource utilization

  • Made in China 2025

  • Health expenditure per capita doubled to 561 € per capita (2019) compared to 2012

  • Growing middle class¹: By 2022 approx. 76% of the urban population

  • Chronic diseases: cause of 89% of deaths and therefore opportunities for German companies to establish innovative pharmaceutical and medical product systems

challenges chinese healthcare market
healthcare China Risks
consulting healthcare China

REGULATORY CHANGES

LIMITED MARKET ACCESS

LACK OF EXPERTISE

  • High bureaucratic hurdles and often non-stringent regulations for foreign companies

 

  • Discrimination in tendering procedures

 

  • Unclear standards and norms for medical devices and drugs

 

  • Frequent regulatory changes and IP protection violations

 

  • Efforts to manufacture domestic medical devices and reduce drug prices

 

  • Foreign direct investments in medical facilities are currently still limited to a joint venture structure

CHALLENGES

Our consulting approach is based on 3 pillars

Fundiertes Fachwissen im Gesundheitswesen

In-depth knowledge
about healthcare in China and Germany

  • Understanding of market dynamics and profound intercultural skills

  • Early detection and optimal value creation of economic, political and technological developments

Netzwerk bei SILREAL

Comprehensive network
for the implementation of customer projects

  • Strategic cooperation partners, investors and public institutions

  • Mediation of relevant contacts at the right time and targeted initiation of sustainable partnerships

Beratungsansatz im Gesundheitswesen

Individual solutions
ensure sustainable customer success

  • Individual market analyzes, strategic corporate planning and goal-oriented business development

  • Successful execution and implementation of China-related projects

Our consulting services in four areas

Pharma & Biotech
Experiment
Doktor Using Digital-Tablette
guillaume-perigois-wVqC9dty3VQ-unsplash_

Our success stories

White Pills

Pharma & Biotech

Client:

German family-run pharmaceutical
company

Project:

Market access analysis of an OTC including evaluation of approval modalities

Key tasks:

  • Consulting project for a leading international pharmaceutical company

  • Overview of the status quo and the development of the digital health market in China

  • Offering a market entry strategy for an integrated digital healthcare provider

Target market:

China